Molecular and cellular mechanisms of aortic stenosis

作者: Ertan Yetkin , Johannes Waltenberger

DOI: 10.1016/J.IJCARD.2009.03.108

关键词:

摘要: Calcific aortic stenosis is the most common cause of valve replacement in developed countries, and this condition increases prevalence with advancing age. The fibrotic thickening calcification are eventual endpoint both non-rheumatic calcific rheumatic stenoses. New observations human valves support hypothesis that degenerative valvular result active bone formation valve, which may be mediated through a process osteoblast-like differentiation these tissues. Additionally histopathologic evidence suggests early lesions not just disease secondary to aging, but an cellular follows classical "response injury hypothesis" similar situation atherosclerosis. Although there similarities risk factor as well atherogenesis, all patients coronary artery or atherosclerosis have stenosis. This review mainly focuses on potential vascular molecular mechanisms involved pathogenesis Namely extracellular matrix remodeling, angiogenesis, inflammation, eventually resulting been shown play role Several mediators related underlying mechanisms, including growth factors especially transforming factor-beta1 endothelial factors, cathepsin enzymes, adhesion molecules, regulatory proteins metalloproteinases demonstrated, however target attacked defined yet.

参考文章(126)
Valentina M. Factor, Erwin P. Böttinger, Snorri S. Thorgeirsson, Jeffrey B. Kopp, Nancy Sanderson, Paul E. Klotman, Peter Nagy, Miklos Mozes, Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Laboratory Investigation. ,vol. 74, pp. 991- 1003 ,(1996)
Sarig S, Okon E, Kahana F, Katz I, Weiss Ta, Azoury R, Kruth Hs, Detection of cholesterol associated with calcium mineral using confocal fluorescence microscopy. Laboratory Investigation. ,vol. 71, pp. 782- 787 ,(1994)
J. J. Kaden, D. C. Vocke, C. S. Fischer, R. Grobholz, M. Brueckmann, C. F. Vahl, S. Hagl, K. K. Haase, C.-E. Dempfle, M. Borggrefe, Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis Zeitschrift Fur Kardiologie. ,vol. 93, pp. 124- 130 ,(2004) , 10.1007/S00392-004-1021-0
E R Mohler rd, F H Gannon, R J Levy, A W Chang, L Graham, M K Chawla, N Vyavahare, Identification and characterization of calcifying valve cells from human and canine aortic valves. Journal of Heart Valve Disease. ,vol. 8, pp. 254- 260 ,(1999)
Waltenberger J, Miyazono K, Heldin Ch, Oberg K, Wilander E, Lundin L, Funa K, Involvement of Transforming Growth Factor-Beta in the Formation of Fibrotic Lesions in Carcinoid Heart Disease American Journal of Pathology. ,vol. 142, pp. 71- 78 ,(1993)
B.Fendley Stewart, David Siscovick, Bonnie K. Lind, Julius M. Gardin, John S. Gottdiener, Vivienne E. Smith, Dalane W. Kitzman, Catherine M. Otto, Clinical Factors Associated With Calcific Aortic Valve Disease Journal of the American College of Cardiology. ,vol. 29, pp. 630- 634 ,(1997) , 10.1016/S0735-1097(96)00563-3
Anderson Hc, Tanimura A, McGregor Dh, Calcification in atherosclerosis. II. Animal studies. Experimental pathology. ,vol. 2, pp. 261- 273 ,(1986)
Linda L. Demer, Cholesterol in Vascular and Valvular Calcification Circulation. ,vol. 104, pp. 1881- 1883 ,(2001) , 10.1161/CIRC.104.16.1881
J Waltenberger, C H Heldin, K Miyazono, A Wanders, K Funa, B Fellström, Induction of transforming growth factor-beta during cardiac allograft rejection. Journal of Immunology. ,vol. 151, pp. 1147- 1157 ,(1993)